Valuation: Maravai LifeSciences Holdings, Inc.

Market Cap 1.12B 1.01B 920M 840M 1.58B 106B 1.63B 11.09B 4.42B 56.3B 4.21B 4.12B 178B P/E 2026 *
-23.5x
P/E 2027 * -28.9x
Enterprise Value 1.22B 1.09B 997M 910M 1.71B 114B 1.77B 12.01B 4.79B 60.98B 4.56B 4.47B 193B EV / Sales 2026 *
5.71x
EV / Sales 2027 * 5.25x
Free-Float
45.47%
Yield 2026 *
-
Yield 2027 * -
1 day+7.74%
1 week-3.71%
Current month-3.71%
1 month-4.20%
3 months+20.32%
6 months+90.86%
Current year+131.38%
1 week 6.8
Extreme 6.8
7.99
1 month 6.33
Extreme 6.334
8.62
Current year 2.8
Extreme 2.8
9.42
1 year 2.8
Extreme 2.8
9.42
3 years 1.66
Extreme 1.665
11.56
5 years 1.66
Extreme 1.665
46.29
10 years 1.66
Extreme 1.665
63.55
Manager TitleAgeSince
Chief Executive Officer 59 2025-06-07
Director of Finance/CFO 59 2025-06-29
Chief Operating Officer - 2025-07-31
Director TitleAgeSince
Director/Board Member 50 2016-02-29
Director/Board Member 65 2020-10-31
Director/Board Member 61 2019-12-31
Date Insider Type Main position Quantity % Market Cap. Importance
10/8/26 Tax

Chief Executive Officer

-29,250 0.0196%
9/30/26 Tax

Chief Financial Officer

-5,465 0.0037%
9/8/26 Tax

Chief Executive Officer

-29,250 0.0196%
Change 5-day change 1-year change 3-year change Capi.($)
+7.74%-3.71%+160.21%+9.94% 1.12B
-4.83%+3.51%+53.62%+61.75% 65.94B
-1.34%+2.98%+24.79%+100.18% 56.53B
+0.02%+1.07%+10.63%+76.66% 56.88B
+5.09%+9.89%+22.45%+107.48% 46.49B
+2.62%+1.68%+28.91%+37.01% 44.8B
+8.24%+0.51%+213.26%+792.66% 41.59B
-1.86%+10.13%+26.82%+53.22% 35.35B
-2.97%-9.84%+88.86%+76.17% 33.29B
-2.18%+7.06%+36.06%-4.95% 24.92B
Average +1.05%+2.56%+66.56%+131.01% 40.69B
Weighted average by Cap. +0.23%+3.38%+53.41%+142.59%

Financials

2026 *2027 *
Net sales 213M 191M 174M 159M 300M 20.01B 310M 2.1B 839M 10.68B 799M 782M 33.7B 225M 202M 184M 168M 317M 21.14B 327M 2.22B 886M 11.28B 844M 826M 35.6B
Net income -61.45M -55.12M -50.37M -45.98M -86.63M -5.78B -89.36M -607M -242M -3.08B -231M -226M -9.73B -54.73M -49.08M -44.86M -40.95M -77.15M -5.14B -79.58M -541M -216M -2.74B -205M -201M -8.67B
Net Debt 93.41M 83.78M 76.57M 69.9M 132M 8.78B 136M 923M 368M 4.69B 351M 343M 14.79B 58.85M 52.79M 48.24M 44.04M 82.97M 5.53B 85.59M 581M 232M 2.95B 221M 216M 9.32B
Projected Income Statement - Annual - Maravai LifeSciences Holdings, Inc.
Logo Maravai LifeSciences Holdings, Inc.
Maravai LifeSciences Holdings, Inc. is a life sciences company providing critical products and services to enable the development of drugs, therapeutics, vaccines, and diagnostics, and support research on human disease. Its segments include TriLink and Cygnus. Its TriLink segment provides nucleic acid products and related services, including messenger ribonucleic acid (mRNA), oligonucleotides, CleanCap mRNA capping technology, ModTail poly(A) tail modification technology, synthesis inputs, nucleoside triphosphates, enzymes, and mRNA manufacturing services. Its Cygnus segment provides biologics safety testing products and services, including host cell protein enzyme-linked immunosorbent assay (ELISA) kits, impurity detection assays, viral clearance prediction tools, ancillary reagents, and custom analytical services. Its TriLink and Cygnus segments produce materials used in research and biopharmaceutical production, clinical trial vaccines and vaccine support products.
Employees
415
Date Price Change Volume
26-11-06 US$7.520 +7.74% 1,936,352
26-11-05 US$6.980 -9.59% 3,211,989
26-11-04 US$7.720 +3.62% 3,624,318
26-11-03 US$7.450 +3.62% 1,905,852
26-11-02 US$7.190 -7.94% 2,292,469
Trader
Investor
Global
Quality
ESG MSCI
BB
MarketScreener Ratings - Maravai LifeSciences Holdings, Inc.
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
9
Last Close Price
7.520USD
Average target price
8.500USD
Spread / Average Target
+13.03%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Maravai LifeSciences Holdings, Inc.
  1. Stock Market
  2. Stocks
  3. MRVI Stock